Erlonat (Erlotinib)

USES OF ERLONAT TABLET

• Non-small cell lung cancer
• Pancreatic cancer

BENEFITS OF ERLONAT TABLET

In Non-small cell lung cancer

Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Erlonat (Erlotinib) Tablet helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.

SIDE EFFECTS OF ERLONAT TABLET

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Erlonat

• Abdominal pain
• Bone pain
• Breathlessness
• Constipation
• Cough
• Diarrhea
• Fatigue
• Fever
• Infection
• Muscle pain
• Nausea
• Rash
• Stomatitis (Inflammation of the mouth)
• Vomiting
• Weight loss

HOW TO USE ERLONAT TABLET

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.Erlonat (Erlotinib) Tablet is to be taken empty stomach.

HOW ERLONAT TABLET WORKS

Erlonat (Erlotinib) Tablet is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger, EGFR, hence, inhibits the cancer signaling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells.

HOW TO USE ERLONAT TABLETHOW TO USE ERLONAT TABLETTake this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Erlonat (Erlotinib) Tablet is to be taken empty stomach.HOW ERLONAT TABLET WORKSErlonat (Erlotinib) Tablet is an anti-cancer medication. Epidermal growth factor receptors (EGFR) are expressed on the lung cancer cell surfaces that modulate their growth. This medicine works by binding the chemical messenger, EGFR, hence, inhibits the cancer signaling pathways mediated by EGFR. This is how it restricts further growth of the cancer cells.

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Erlonat (Erlotinib)Tablet. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

Erlonat (Erlotinib) Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Erlonat (Erlotinib) Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

CONSULT YOUR DOCTOR

It is not known whether Erlonat (Erlotinib) Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Kidney

SAFE IF PRESCRIBED

Erlonat (Erlotinib) Tablet is safe to use in patients with kidney disease. No dose adjustment of Erlonat (Erlotinib) Tablet is recommended.
Use of this medicine is not advised in patients with severe kidney disease.

Liver

CAUTION

Erlonat (Erlotinib) Tablet should be used with caution in patients with liver disease. Dose adjustment of Erlonat (Erlotinib) Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Erlonat (Erlotinib) Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.